LEAP2 and obesity disorder: In line with our data in ob/ob mice, we also found an anorexigenic effect of LEAP-2 in ghrelin-induced food intake in another obesity model, the DIO mice, which is in clear contrast to the leptin-resistant state observed in DIO mice and highlights its potential translational relevance.